Nls Pharmaceutics Ag logo

Nls Pharmaceutics Ag Share Price Today

(NASDAQ: NLSP)

Nls Pharmaceutics Ag share price is $1.54 & ₹133.93 as on 6 Mar 2025, 2.30 'hrs' IST

$1.54

-0.06

(-3.75%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Nls Pharmaceutics Ag share price in Dollar and Rupees. Guide to invest in Nls Pharmaceutics Ag stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Nls Pharmaceutics Ag, along with analyst recommendations, forecasts, and comprehensive financials.

Nls Pharmaceutics Ag share price movements

  • Today's Low: $1.51
    Today's High: $1.60

    Day's Volatility :5.71%

  • 52 Weeks Low: $1.54
    52 Weeks High: $18.39

    52 Weeks Volatility :91.62%

Nls Pharmaceutics Ag (NLSP) Returns

PeriodNls Pharmaceutics AgIndex (Russel 2000)
3 Months
-28.89%
0.0%
6 Months
-71.85%
0.0%
1 Year
-88.7%
0.0%
3 Years
-97.33%
-11.6%

Nls Pharmaceutics Ag (NLSP) Key Statistics

in dollars & INR

Previous Close
$1.6
Open
$1.6
Today's High
$1.6
Today's Low
$1.5087
Market Capitalization
$7.2M
Today's Volume
$2.5K
52 Week High
$18.388
52 Week Low
$1.5087
Revenue TTM
$0.0
EBITDA
$-6.3M
Earnings Per Share (EPS)
$-6.67
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-862.92%

How to invest in Nls Pharmaceutics Ag Stock (NLSP) from India?

It is very easy for Indian residents to invest directly in Nls Pharmaceutics Ag from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nls Pharmaceutics Ag stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nls Pharmaceutics Ag or NLSP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nls Pharmaceutics Ag or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nls Pharmaceutics Ag shares which would translate to 0.565 fractional shares of Nls Pharmaceutics Ag as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Nls Pharmaceutics Ag, in just a few clicks!

Returns in Nls Pharmaceutics Ag (NLSP) for Indian investors in Rupees

The Nls Pharmaceutics Ag stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Nls Pharmaceutics Ag investment value today

Current value as on today

₹15,838

Returns

₹84,162

(-84.16%)

Returns from Nls Pharmaceutics Ag Stock

₹89,124 (-89.12%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Nls Pharmaceutics Ag (NLSP)

26%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Nls Pharmaceutics Ag Stock from India on INDmoney has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Nls Pharmaceutics Ag

  • Bvf Inc

    3.54%

  • UBS Group AG

    0.20%

Analyst Recommendation on Nls Pharmaceutics Ag

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Nls Pharmaceutics Ag(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
6
Hold
3
3
2
Sell
3
3
0

Analyst Forecast on Nls Pharmaceutics Ag Stock (NLSP)

What analysts predicted

Upside of 289.61%

Target:

$6.00

Current:

$1.54

Insights on Nls Pharmaceutics Ag Stock (Ticker Symbol: NLSP)

  • Price Movement

    In the last 6 months, NLSP stock has moved down by -71.9%
  • NLSP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 151.0%
  • NLSP vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 144.9%

Nls Pharmaceutics Ag Technicals Summary

Sell

Neutral

Buy

Nls Pharmaceutics Ag is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Nls Pharmaceutics Ag (NLSP) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Nls Pharmaceutics Ag logo
-20.0%
-71.85%
-88.7%
-97.33%
-98.62%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Nls Pharmaceutics Ag logo
NA
NA
NA
0.0
-8.63
-2.28
NA
-9.4
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Nls Pharmaceutics Ag logo
Sell
$7.2M
-98.62%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Nls Pharmaceutics Ag

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol for the treatment of ADHD. The company also developing NLS-4, a selective dopamine reuptake inhibitor treatment for the chronic fatigue associated with the symptoms of Long-COVID; NLS-3, a repurposed reverse ester of methylphenidate for treatment of ADHD; NLS-8, a melatonin ML1A receptor agonist for improved scopolamine-induced amnesia; NLS-11, a norepinephrine and dopamine reuptake inhibitor and muscarinic M1, M2, M3 receptor antagonist; and NLS-12, a norepinephrine and dopamine reuptake inhibitor and muscarinic M4 receptor antagonist. It has licensing agreements with NeuroLife-Sciences SAS for use of mazindol for the treatment of ADHD; and Eurofarma Laboratorios S.A. for commercialization and distribution of Nolazol in Latin America. NLS Pharmaceutics AG was incorporated in 2015 and is based in Zurich, Switzerland.
Organization
Nls Pharmaceutics Ag
Employees
0
CEO
Mr. Alexander Zwyer M.B.A.
Industry
Health Technology

Management People of Nls Pharmaceutics Ag

NameTitle
Mr. Alexander Zwyer M.B.A.
Co-Founder, CEO & Director
Dr. Eric Konofal M.D., Ph.D.
Co-Founder & Chief Scientific Officer
Dr. George Apostol M.D.
Chief Medical Officer and Global Head of Research & Development

Important FAQs about investing in NLSP Stock from India :

What is Nls Pharmaceutics Ag share price today?

Nls Pharmaceutics Ag share price today stands at $1.54, Open: $1.60 ; Previous Close: $1.60 ; High: $1.60 ; Low: $1.51 ; 52 Week High: $18.39 ; 52 Week Low: $1.54.

The stock opens at $1.60, after a previous close of $1.60. The stock reached a daily high of $1.60 and a low of $1.51, with a 52-week high of $18.39 and a 52-week low of $1.54.

Can Indians buy Nls Pharmaceutics Ag shares?

Yes, Indians can invest in the Nls Pharmaceutics Ag (NLSP) from India.

With INDmoney, you can buy Nls Pharmaceutics Ag at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Nls Pharmaceutics Ag at zero transaction cost.

How can I buy Nls Pharmaceutics Ag shares from India?

It is very easy to buy Nls Pharmaceutics Ag from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nls Pharmaceutics Ag (NLSP) be purchased?

Yes, you can buy fractional shares of Nls Pharmaceutics Ag with INDmoney app.

What are the documents required to start investing in Nls Pharmaceutics Ag stocks?

To start investing in Nls Pharmaceutics Ag, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Nls Pharmaceutics Ag Stock (NLSP)?

Today’s highest price of Nls Pharmaceutics Ag (NLSP) is $1.60.

Today’s lowest price of Nls Pharmaceutics Ag (NLSP) is $1.51.

What is today's market capitalisation of Nls Pharmaceutics Ag?

Today's market capitalisation of Nls Pharmaceutics Ag NLSP is 7.2M

What is the 52 Week High and Low Range of Nls Pharmaceutics Ag Stock (NLSP)?

  • 52 Week High

    $18.39

  • 52 Week Low

    $1.54

What are the historical returns of Nls Pharmaceutics Ag (NLSP)?

  • 1 Month Returns

    -20%

  • 3 Months Returns

    -71.85%

  • 1 Year Returns

    -88.7%

  • 5 Years Returns

    -98.62%

Who is the Chief Executive Officer (CEO) of Nls Pharmaceutics Ag ?

Mr. Alexander Zwyer M.B.A. is the current Chief Executive Officer (CEO) of Nls Pharmaceutics Ag.